reports
EQS-News: BB Biotech presents solid first-quarter results; biotech sto...
EQS-News: BB BIOTECH AG / Key word(s): Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates 26.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at April 26, 2024 Portfolio of BB Biotech AG as at March 31, 2024 BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates Investor sentiment in the biotech space continues to be shaped by the general interest rate environment. Biot...
EQS-News: BB Biotech mit solidem Quartalsergebnis, Biotechkapitalmarkt...
EQS-News: BB BIOTECH AG / Schlagwort(e): Zwischenbericht BB Biotech mit solidem Quartalsergebnis, Biotechkapitalmarkt von Zinserwartungen geprägt 26.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Medienmitteilung vom 26. April 2024 Portfolio der BB Biotech AG per 31. März 2024 BB Biotech mit solidem Quartalsergebnis, Biotechkapitalmarkt von Zinserwartungen geprägt Das Zinsumfeld bestimmt weiterhin massgeblich die Stimmung der Biotechinvestoren. Die Aktienkurse entwickelten sich zu Beginn des Jahres vielversprechend...
EINLADUNG ZUR AUSSERORDENTLICHEN GENERALVERSAMMLUNG 2024 DER AKTIONÄRE...
Novavest Real Estate AG / Schlagwort(e): Generalversammlung EINLADUNG ZUR AUSSERORDENTLICHEN GENERALVERSAMMLUNG 2024 DER AKTIONÄRE DER NOVAVEST REAL ESTATE AG 26.04.2024 / 07:00 CET/CEST Sehr geehrte Damen und Herren Im Anhang finden Sie zu Ihrer Information eine Kopie der Einladung zur ausserordentlichen Generalversammlung der Novavest Real Estate AG vom 29. Mai 2024. Kontaktperson: Peter Mettler Chief Executive Officer NOVAVEST Real Estate AG Feldeggstrasse 26 8008 Zürich +41 (0)44 276 40 40 NOVAVEST Real Estate AG Die NOVAVEST Real Estate AG ist eine Schweizer Immobili...
EQS-News: PALFINGER AG mit hervorragendem Ergebnis im 1. Quartal
EQS-News: Palfinger AG / Schlagwort(e): Quartalsergebnis PALFINGER AG mit hervorragendem Ergebnis im 1. Quartal 26.04.2024 / 07:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNG Bergheim, Österreich am 26. April 2024PALFINGER AG mit hervorragendem Ergebnis im 1. Quartal Umsatz von EUR 578,5 Mio., Bestmarken im EBIT von EUR 54,7 Mio. und Konzernergebnis von EUR 32,5 Mio. Gute Entwicklung in Nordamerika, Asien und im Bereich Marine Anhaltend geringer Auftragseingang in europäischen Kernmärkten ...
EQS-News: PALFINGER AG: Outstanding results for PALFINGER AG in the fi...
EQS-News: Palfinger AG / Key word(s): Quarter Results PALFINGER AG: Outstanding results for PALFINGER AG in the first quarter 26.04.2024 / 07:01 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Bergheim, Austria, April 26, 2024Outstanding results for PALFINGER AG in the first quarter EUR 578.5 million revenue, record EBIT of EUR 54.7 million and consolidated net result of EUR 32.5 million Good development in North America, Asia and the Marine Sector Continued low order intake in European core mar...
Elevance Health Inc: 1 director
A director at Elevance Health Inc sold/sold after exercising options 20,310 shares at 533.316USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
EQS-News: STRATEC BERICHTET ZAHLEN ZUM ERSTEN QUARTAL 2024
EQS-News: STRATEC SE / Schlagwort(e): Quartalsergebnis STRATEC BERICHTET ZAHLEN ZUM ERSTEN QUARTAL 2024 26.04.2024 / 06:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRATEC BERICHTET ZAHLEN ZUM ERSTEN QUARTAL 2024 Erwartungsgemäß verhaltener Start ins Geschäftsjahr, jedoch spürbare Marktbelebung beobachtbar und sehr starkes Umsatzwachstum im zweiten Quartal 2024 erwartet Konzernumsatz in Q1/2024 währungsbereinigt -15,7% bei 50,9 Mio. € (Q1/2023: 60,5 Mio. €) Effizienzmaßnahmen und strukturelle Änderung entfalten Wirkung: Adju...
EQS-News: STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024
EQS-News: STRATEC SE / Key word(s): Quarter Results STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 26.04.2024 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 Subdued start to financial year as expected, but noticeable revival apparent in market and very strong sales growth expected for second quarter of 2024 Consolidated sales Q1/2024 -15.7% at constant currency to € 50.9 million (Q1/2023: € 60.5 million) Efficiency measures and structural changes taking effect: Despite negative s...
EQS-News: Branicks Group erweitert Geschäftsmodell um Asset-Klasse Ren...
EQS-News: Branicks Group AG / Schlagwort(e): Immobilien/Nachhaltigkeit Branicks Group erweitert Geschäftsmodell um Asset-Klasse Renewables und kooperiert dabei mit der Encavis Asset Management AG 26.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Branicks Group erweitert Geschäftsmodell um Asset-Klasse Renewables und kooperiert dabei mit der Encavis Asset Management AG Frankfurt, 26. 04. 2024 – Die Branicks Group AG (Branicks), ISIN: DE000A1X3XX4, verstärkt den Fokus auf operative Wertsteigerungen und zusätzlich...
EQS-News: Branicks Group expands business model to include renewables ...
EQS-News: Branicks Group AG / Key word(s): Real Estate/Sustainability Branicks Group expands business model to include renewables asset class and cooperates with Encavis Asset Management AG 26.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Branicks Group expands business model to include renewables asset class and cooperates with Encavis Asset Management AG Frankfurt, 26. 04. 2024 – Branicks Group AG (Branicks), ISIN: DE000A1X3XX4, is strengthening its focus on operational value enhancement and additional return potenti...
- ABGSC Retail Research
- Benjamin Wahlstedt
- Fredrik Ivarsson
Sopra Steria : Un 1er trimestre 2024 conforme aux prévisions
PARIS--(BUSINESS WIRE)-- Regulatory News: Le chiffre d’affaires du 1er trimestre 2024 de Sopra Steria (Paris:SOP) s’est élevé à 1 587,4 M€, en croissance de 13,8%. A périmètre et taux de change constants, le chiffre d’affaires a augmenté de 0,3 %. Sopra Steria : chiffre d'affaires consolidé du 1er trimestre 2024 M€ / % T1 2024 T1 2023 Croissanceorganique Croissancetotale Chiffre d'affaires 1 587,4 1 395,4 0,3% 13,8% Cyril Malargé, Directeur Général de Sopra Steria Group, a déclaré : « Sur le 1er trimestre 2024, dans un marché toujours porteur pour les grand...
IMCD reports EBITA of EUR 127 million in the first three months of 202...
IMCD reports EBITA of EUR 127 million in the first three months of 2024 Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first three months 2024 results. HIGHLIGHTS Gross profit of EUR 295 million (on a constant currency basis, equal to the first three months of 2023)Operating EBITA decline of 15% to EUR 127 million (-13% on a constant currency basis)Free cash flow of EUR 106 million (first three months of 2023: EUR 147 million)Cash earnings p...
Peugeot Sport Aims for the Endurance Racing Finish Line With Simulatio...
PARIS--(BUSINESS WIRE)-- (Euronext Paris: FR0014003TT8, DSY.PA) and , the motorsports division of Stellantis, today announced their partnership to simulate and optimize the aerodynamics of the PEUGEOT 9X8 Hybrid Hypercar for the 2024 endurance racing season, and demonstrate high-performing electric mobility in motorsports that creates value for Stellantis’ automotive brands. This press release features multimedia. View the full release here: Image courtesy of Peugeot Sport Dassault Systèmes’ SIMULIA PowerFLOW application, powered by the 3DEXPERIENCE platform, was used to create a virtual twi...
Corbion: Q1 2024 Interim Management Statement
Corbion: Q1 2024 Interim Management Statement Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2024. Key highlights first quarter of 2024 Organic growth core activities: Sales: volume/mix +1.7%, price -4.5%Adjusted EBITDA: +0.7%Adjusted EBITDA margin 13.8% (+ 50bps versus last year) Sales € 344.3 million; an organic decrease of -3.4%Adjusted EBITDA € 47.2 million; an organic decrease of -1.2%Positive Free Cash Flow € 7.5 millionDouble digit growth in sal...
Hexatronic Group AB (publ) Interim report January – March 2024
Hexatronic Group AB (publ) Interim report January – March 2024 Hexatronic Group AB (publ)Interim report January – March 2024 Continued strong operating cash flow and contribution from new focus areas First quarter (January 1 – March 31, 2024) Net sales decreased by 16 percent to MSEK 1,782 (2,115). Sales decreased organically by 27 percent.EBITA decreased by 54 percent to MSEK 168 (365), corresponding to an EBITA margin of 9.4 percent (17.2).Operating profit (EBIT) decreased by 59 percent to MSEK 138 (340), corresponding to an operating margin of 7.7 percent (16.1).Net profit decreased b...
- Marc Hesselink
- CFA
- Thymen Rundberg
Melexis/Slower growth period/HOLD
Melexis reported a comforting 1Q24 update pointing towards an end of destocking. The company is performing relatively well taking into account the weakness in automotive production. This is supported by R&D driving good levels of design wins. We leave our estimates largely unchanged but we still expect below average growth for 2024-25F on the back of limited car production growth and above-average price pressure. We reiterate our HOLD rating and maintain our DCF-based target of €85.
- Stijn Demeester
AMG/1Q24 preview and model update/BUY
We update our model ahead of AMG's 1Q24 results. While current lacklustre market conditions provide limited room for positive earnings surprises in the short term, we continue to see attractive mid-term earnings growth potential on the back of capacity expansions in Lithium Brazil and Germany. We reiterate our BUY on a lowered target price of €30 per share.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.